Among the 12% of adults who have ever taken GLP-1 drugs, most report taking them, at least in part, to treat a chronic condition like diabetes or heart disease, with fewer saying they took them only to lose weight
This is a structural difference from research-grade GHK-Cu sold as a lyophilized powder, where the user has to source bac water separately (currently on national shortage) and reconstitute by hand
Through Q1 2024, theyre still by far the most-searched drugs by RxSS membersand no doubt among the broader population, too
Two prediction models were built, one with 39 high-TMAO-correlated OTUs and the other with the whole OTU dataset (1637 OTUs)
Protein becomes the priority
GLP-1 Receptor Agonists - Podcast Version GLP-1 (glucagon-like peptide-1) receptor agonists are injectable medicines used for the treatment of type 2 diabetes and, more recently, for weight management